Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Perspective - Journal of Clinical Oncology and Cancer Research (2023) Volume 6, Issue 3

Pathological Diagnosis of Cancer: Insights from Tissue Examination

William Jon*

Department of Pathology, Johns Hopkins' University School of Medicine, Baltimore, USA

*Corresponding Author:
William Jon
Department of Pathology
Johns Hopkins' University School of Medicine
Baltimore, USA
E-mail: Richard@fcc.edu

Received: 03-Jun-2023, Manuscript No.AACOCR-23-104455; Editor assigned: 06-Jun-2023, PreQC No.AACOCR-23-104455 (PQ); Reviewed: 20-Jun-2023, QC No.AACOCR-23-104455; Revised: 22-Jun-2023, Manuscript No.AACOCR-23-104455 (R); Published: 27-Jun-2023, DOI:10.35841/aacocr-6.3.153

Citation: Jon W. Pathological diagnosis of cancer: Insights from tissue examination. J Clin Oncol Cancer Res. 2023; 6(3):153

Visit for more related articles at Journal of Clinical Oncology and Cancer Research

Introduction

Pathological diagnosis plays a pivotal role in the management of cancer patients, providing crucial information about tumor type, grade, stage, and molecular characteristics. Pathologists, through the examination of tissue specimens and the use of various techniques, contribute to accurate cancer classification, prognosis determination, and treatment planning. This article explores the importance of pathological diagnosis in cancer care, the techniques employed, and the role of pathologists in guiding personalized treatment decisions [1].

a. Accurate tumor classification: Pathologists determine the precise tumor type, distinguishing between different cancers and subtypes. This information is crucial for selecting appropriate treatment strategies and predicting prognosis [2].

b. Tumor grading: Pathologists assess the tumor grade, evaluating the degree of cellular differentiation and proliferation. Grading helps determine the aggressiveness of the tumor and guides treatment decisions.

c. Staging and prognosis: Pathological evaluation provides vital information for cancer staging, which involves assessing tumor size, extent of local invasion, lymph node involvement, and the presence of distant metastases. Staging helps determine prognosis and guides treatment planning.

d. Molecular characterization: Pathological assessment includes the identification of specific molecular alterations and biomarkers that can influence treatment decisions, such as hormone receptor status in breast cancer or EGFR mutations in lung cancer [3].

Techniques used in pathological diagnosis

a. Histopathology: Histopathological examination involves the analysis of tissue samples under a microscope. Pathologists assess cellular and tissue characteristics, identifying tumor type, grade, and features such as invasion or necrosis. Staining techniques, such as hematoxylin and eosin (H&E), highlight tissue structures and help in tumor identification [4].

b. Immunohistochemistry (IHC): IHC utilizes specific antibodies to detect and visualize proteins within tumor cells. It aids in determining the expression of markers, such as hormone receptors (e.g., estrogen and progesterone receptors) or Human Epidermal Growth Factor Receptor 2 (HER2), which guide targeted therapy decisions.

c. Molecular pathology: Molecular pathology techniques analyze the genetic and molecular alterations within cancer cells. Polymerase Chain Reaction (PCR) and Fluorescence In Situ Hybridization (FISH) can detect gene mutations, amplifications, or rearrangements associated with specific cancers. These techniques help identify targeted therapy options and predict treatment response.

d. Next-Generation Sequencing (NGS): NGS enables comprehensive analysis of tumor DNA, identifying genetic alterations and mutations. Whole-Genome Sequencing (WGS) and targeted gene panel sequencing help identify actionable mutations and guide personalized treatment decisions.

Pathologists play a crucial role throughout the cancer care continuum:

a. Tissue sampling and biopsy: Pathologists are responsible for obtaining high-quality tissue samples through biopsies or surgical resections. They ensure proper handling and preservation of specimens to obtain accurate diagnostic information.

b. Diagnosis and classification: Pathologists analyze tissue samples and provide an accurate diagnosis, identifying the specific tumor type and subtype. This information is crucial for selecting appropriate treatment options.

c. Tumor staging: Pathologists assess the extent of tumor spread, examining lymph nodes and evaluating the presence of metastasis. Staging information helps determine treatment strategies, predict prognosis, and facilitate communication among multidisciplinary teams.

d. Molecular profiling and biomarker assessment: Pathologists identify molecular alterations and biomarkers, providing critical information for targeted therapy decisions. They collaborate with molecular pathologists to ensure accurate testing and interpretation of results.

e. Quality assurance and quality improvement: Pathologists are responsible for maintaining high-quality standards [5].

Conclusion

The conclusion of a pathological diagnosis provides crucial information for guiding treatment decisions and predicting patient outcomes. It is typically included in the pathology report and discussed with the patient's healthcare team to develop an appropriate management plan. It is important to note that the exact wording and format of the conclusion may vary depending on the practices and standards of the specific pathology laboratory.

References

  1. Travis WD, Rekhtman N. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. Semin Respir Crit Care Med. 2011.

    2. Indexed at, Google Scholar, Cross Ref

  2. Travis WD. Pathology of lung cancer. Clin Chest Med. 2011;32(4):669-92.

    3. Google Scholar

  3. DeMarzo AM, Nelson WG, Isaacs WB, et al. Pathological and molecular aspects of prostate cancer. The Lancet. 2003;361(9361):955-64.

    4. Indexed at, Google Scholar, Cross Ref

  4. Leong AS, Zhuang Z. The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology. 2011;78(2):99-114.

    5. Indexed at, Google Scholar, Cross Ref

  5. Haka AS, Shafer-Peltier KE, Fitzmaurice M, et al. Diagnosing breast cancer by using Raman spectroscopy. Proc Natl Acad Sci. 2005;102(35):12371-6.

    6. Indexed at, Google Scholar, Cross Ref

Get the App